...
首页> 外文期刊>Catheterization and cardiovascular interventions: Official journal of the Society for Cardiac Angiography & Interventions >Evaluation of contrast agents for delineation of vessel wall boundary by intracoronary ultrasound after coronary angioplasty in human.
【24h】

Evaluation of contrast agents for delineation of vessel wall boundary by intracoronary ultrasound after coronary angioplasty in human.

机译:评估人冠状动脉成形术后通过冠状动脉内超声划定血管壁边界的造影剂。

获取原文
获取原文并翻译 | 示例
           

摘要

We evaluated the potential for improving visualization at intervention sites using contrast-enhanced intracoronary ultrasound (ICUS) and the suitable contrast agents for this procedure in humans. In 37 patients, ICUS (30 MHz) was performed with intracoronary bolus injection (3 mL) of seven different contrast preparations and without the contrast agents (control) after coronary intervention. The contrast agents used were as follows: saline solution, standard iomeprol, standard ioxaglate, sonicated iomeprol, sonicated ioxaglate, 50% Albunex, and 100% Albunex. Homogeneous and complete opacification of the vessel lumen and false lumen was observed with sonicated ioxaglate, 50% and 100% Albunex. Shadowing was not observed at all with sonicated ioxaglate and was uncommon with 50% Albunex, whereas 100% Albunex caused shadowing in all cases. The coronary delineation rate with the other contrast agents was only 60%-70%, and the homogeneity and peak intensity were relatively low. Thus, sonicated ioxaglate and 50% Albunex both achieved good visualization, but the latter is more expensive, more difficult to handle, and takes longer to prepare. Of the agents we studied, sonicated ioxaglate appears to be best suited for contrast-enhanced ICUS. ICUS using suitable contrast agents could only visualize the large dissections and the strategy was changed according to the contrast-enhanced ICUS results in five cases. Thus, suitable contrast agents, e.g., sonicated ioxaglate, should be used during ICUS after intracoronary intervention.
机译:我们评估了使用造影剂增强型冠状动脉内超声(ICUS)和适用于人类手术的合适造影剂改善介入部位可视化的潜力。在37例患者中,通过冠状动脉内推注(3 mL)的七种不同造影剂对ICUS(30 MHz)进行了治疗,并且没有造影剂(对照)。所使用的造影剂如下:盐水溶液,标准的碘美普尔,标准的碘克沙特,超声处理的碘美普尔,超声处理的碘克沙特,50%Albunex和100%Albunex。用超声处理的ioxaglate,50%和100%Albunex观察到血管腔和假腔的均质和完全不透明。超声处理的ioxaglate根本没有观察到阴影,在50%的Albunex中很少见,而在所有情况下100%的Albunex都会引起阴影。其他造影剂对冠状动脉的描绘率仅为60%-70%,均一性和峰强度均较低。因此,超声处理的ioxaglate和50%Albunex均可达到良好的可视化效果,但后者更昂贵,更难处理且准备时间更长。在我们研究的药物中,超声处理的ioxaglate似乎最适合于增强造影剂的ICUS。使用合适的造影剂的ICUS只能看到较大的夹层,并且根据5例造影剂增强的ICUS结果改变了策略。因此,在冠状动脉内介入治疗后的ICUS期间应使用合适的造影剂,例如超声处理的ioxaglate。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号